Growth patterns and the use of growth hormone in the mucopolysaccharidoses

Journal of Pediatric Rehabilitation Medicine

Volumn 3, Issue 1, 2010, Pages 25-38

  Polgreen, Lynda E ^a   Miller, B S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Endocrine disease; Growth; Growth hormone; MPS; Mucopolysaccharidoses

Indexed keywords

ESTROGEN; LARONIDASE; RECOMBINANT GROWTH HORMONE;

BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE DYSPLASIA; BONE GROWTH; BONE TURNOVER; DELAYED PUBERTY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; ENZYME REPLACEMENT; GROWTH HORMONE DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; KYPHOSCOLIOSIS; KYPHOSIS; LOW DRUG DOSE; MAROTEAUX LAMY SYNDROME; MORQUIO SYNDROME; NOONAN SYNDROME; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; SANFILIPPO SYNDROME; SCOLIOSIS; SHORT STATURE; SLIPPED CAPITAL FEMORAL EPIPHYSIS; TURNER SYNDROME; WHOLE BODY RADIATION;

EID: 77953415192     PISSN: 18745393     EISSN: 18758894     Source Type: Journal    
DOI: 10.3233/PRM-2010-0106     Document Type: Review

References (103)

1. S. Abreu, J. Hayden, P. Berthold, I.M. Shapiro, S. Decker, D. Patterson and M. Haskins, Growth plate pathology in feline mucopolysaccharidosis VI, Calcif Tissue Int 57 (1995), 185-190.
2. O. Ali, M. Shim, E. Fowler, M. Greenberg, D. Perkins, W. Oppenheim and P. Cohen, Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study, J Clin Endocrinol Metab 92 (2007), 932-937.
3. O. Ali, M. Shim, E. Fowler, P. Cohen and W. Oppenheim, Spinal bone mineral density, IGF-1 and IGFBP-3 in children with cerebral palsy, Horm Res 68 (2007), 316-320.
4. S. Appan, S. Laurent, M. Chapman, P.C. Hindmarsh and C.G. Brook, Growth and growth hormone therapy in hypochondroplasia, Acta Paediatr Scand 79 (1990), 796-803.
5. J. Argente, R. Gracia, L. Ibanez, A. Oliver, E. Borrajo, A. Vela, J.P. Lopez-Siguero, M.L. Moreno and F. Rodriguez- Hierro, Improvement in growth after two years of growth hormone therapy in very young children born small for gestational age and without spontaneous catch-up growth: results of a multicenter, controlled, randomized, open clinical trial, J Clin Endocrinol Metab 92 (2007), 3095-3101.
6. M. Ari, V.K. Bakalov, S. Hill and C.A. Bondy, The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome, J Clin Endocrinol Metab 91 (2006), 4302-4305.
7. L.I. Arwert, D.J. Veltman, J.B. Deijen, P.S. van Dam and M.L. Drent, Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study, Neuroendocrinology 83 (2006), 12-19.
8. J.L. Ashworth, S. Biswas, E. Wraith and I.C. Lloyd, The ocular features of the mucopolysaccharidoses, Eye 20 (2006), 553-563.
9. G. Bach, R. Friedman, B. Weissmann and E.F. Neufeld, The defect in the Hurler and Scheie syndromes: deficiency of alpha-L-iduronidase, Proc Natl Acad Sci USA 69 (1972), 2048-2051.
10. B. Bakker, G.G. Massa, W. Oostdijk, M.H. Van Weel- Sipman, J.M.Vossen and J.M.Wit, Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies, Eur J Pediatr 159 (2000), 31-37.
11. B. Bakker, W. Oostdijk, D. Bresters, M.J. Walenkamp, J.M. Vossen and J.M. Wit, Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood, Bone Marrow Transplant 33 (2004), 1049-1056.
12. G.I. Baroncelli, S. Bertelloni, C. Ceccarelli, D. Cupelli and G. Saggese, Dynamics of bone turnover in children with GH deficiency treated with GH until final height, Eur J Endocrinol 142 (2000), 549-556. (Pubitemid 30399483)
13. G. Bocca, C.M. Weemaes, I. van der Burgt and B.J. Otten, Growth hormone treatment in cartilage-hair hypoplasia: effects on growth and the immune system, J Pediatr Endocrinol Metab 17 (2004), 47-54.
14. K. Bolar, A.R. Hoffman, T. Maneatis and B. Lippe, Long- Term Safety of Recombinant Human Growth Hormone in Turner Syndrome, J Clin Endocrinol Metab (2007), jc.2007- 1723.
15. E.A. Braunlin, A.G. Rose, J.J. Hopwood, R.D. Candel andW. Krivit, Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome, Am J Cardiol 88 (2001), 1075-1077.
16. E.A. Braunlin, J.M. Berry and C.B. Whitley, Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I, Am J Cardiol 98 (2006), 416-418.
17. E.A. Braunlin, N.R. Stauffer, C.H. Peters, J.L. Bass, J.M. Berry, J.J. Hopwood and W. Krivit, Usefulness of bone marrow transplantation in the Hurler syndrome, Am J Cardiol 92 (2003), 882-886.
18. B.M. Brennan and S.M. Shalet, Endocrine late effects after bone marrow transplant, Br J Haematol 118 (2002), 58-66.
19. C.P. Burren and G.A.Werther, Skeletal dysplasias: response to growth hormone therapy, J Pediatr Endocrinol Metab 9 (1996), 31-40.
20. S. Byers, J.D. Nuttall, A.C. Crawley, J.J. Hopwood, K. Smith and N.L. Fazzalari, Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI, Bone 21 (1997), 425-431. (Pubitemid 27485311)
21. J.D. Cody, M. Semrud-Clikeman, L.J. Hardies, J. Lancaster, P.D. Ghidoni, R.L. Schaub, N.M. Thompson, L. Wells, J.E. Cornell, T.M. Love, P.T. Fox, R.J. Leach, C.I. Kaye and D.E. Hale, Growth hormone benefits children with 18q deletions, Am J Med Genet A 137 (2005), 9-15.
22. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society, J Clin Endocrinol Metab 85 (2000), 3990-3993.
23. J. Cox-Brinkman, J.J. Boelens, J.E. Wraith, A. O'Meara, P. Veys, F.A. Wijburg, N. Wulffraat and R.F. Wynn, Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome, Bone Marrow Transplant 38 (2006), 17-21.
24. G. Day, I. McPhee, J. Batch and F. Tomlinson, Growth rates and the prevalence and progression of scoliosis in shortstatured children on Australian growth hormone treatment programmes, Scoliosis 2 (2007).
25. D.J. DiGirolamo, A. Mukherjee, K. Fulzele, Y. Gan, X. Cao, S.J. Frank and T.L. Clemens, Mode of growth hormone action in osteoblasts, J Biol Chem 282 (2007), 31666-31674.
26. P.L. Docquier, M. Mousny, M. Jouret, C. Bastin and J.J. Rombouts, Orthopaedic concerns in children with growth hormone therapy, Acta Orthop Belg 70 (2004), 299-305.
27. S.C. Dusing, D. Thorpe, A. Rosenberg, V. Mercer and M.L. Escolar, Gross motor abilities in children with Hurler syndrome, Dev Med Child Neurol 48 (2006), 927-930.
28. M. Ernst and E.R. Froesch, Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I, Biochem Biophys Res Commun 151 (1988), 142-147.
29. S. Esposito, N. Balzano, A. Daniele, G.R.Villani, K. Perkins, B. Weber, J.J. Hopwood and P. Di Natale, Heparan Nsulfatase gene: two novel mutations and transient expression of 15 defects, Biochim Biophys Acta 1501 (2000), 1-11.
30. R.E. Field, J.A. Buchanan, M.G. Copplemans and P.M. Aichroth, Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development, J Bone Joint Surg Br 76 (1994), 975-981.
31. P. Frisk, J. Arvidson, J. Gustafsson and G. Lönnerholm, Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia, Bone Marrow Transplantation 33 (2004), 205-210.
32. G. Giorgiani, M. Bozzola, F. Locatelli, P. Picco, M. Zecca, M. Cisternino, S. Dallorso, F. Bonetti, G. Dini, C. Borrone et al., Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone, Blood 86 (1995), 825-831.
33. S.E. Gollust, R.E. Thompson, H.C. Gooding and B.B. Biesecker, Living with achondroplasia in an average-sized world: an assessment of quality of life, Am J Med Genet A 120A (2003), 447-458.
34. E.N. Gonc and N. Kandemir, Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency, Clin Endocrinol (Oxf) 66 (2007), 672-677.
35. G. Gotherstrom, B.A. Bengtsson, I. Bosaeus, G. Johannsson and J. Svensson, Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GHdeficiency, Eur J Endocrinol 156 (2007), 55-64.
36. S.S. Grewal, R. Wynn, J.E. Abdenur, B.K. Burton, M. Gharib, C. Haase, R.J. Hayashi, S. Shenoy, D. Sillence, G.E. Tiller, M.E. Dudek, A. van Royen-Kerkhof, J.E. Wraith, P. Woodard, G.A. Young, N. Wulffraat, C.B. Whitley and C. Peters, Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome, Genet Med 7 (2005), 143-146.
37. D. Harada, Y. Yamanaka, K. Ueda, J. Shimizu, M. Inoue, Y. Seino and H. Tanaka, An effective case of growth hormone treatment on cartilage-hair hypoplasia, Bone 36 (2005), 317-322.
38. P. Harmatz, R. Giugliani, I. Schwartz, N. Guffon, E.L. Teles, M.C. Miranda, J.E. Wraith, M. Beck, L. Arash, M. Scarpa, Z.F.Yu, J.Wittes, K.I. Berger, M.S. Newman, A.M. Lowe, E. Kakkis and S.J. Swiedler, Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, doubleblind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study, J Pediatr 148 (2006), 533-539.
39. P. Harmatz, R. Giugliani, I.V. Schwartz, N. Guffon, E.L. Teles, M.C. Miranda, J.E. Wraith, M. Beck, L. Arash, M. Scarpa, D. Ketteridge, J.J. Hopwood, B. Plecko, R. Steiner, C.B. Whitley, P. Kaplan, Z.F. Yu, S.J. Swiedler and C. Decker, Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase, Mol Genet Metab 94 (2008), 469-475.
40. K.A. Hartley, C. Li, F.H. Laningham, M.J. Krasin, X. Xiong and T.E. Merchant, Vertebral body growth after craniospinal irradiation, Int J Radiat Oncol Biol Phys 70 (2008), 1343-1349.
41. R.L. Hintz, K.M. Attie, J. Baptista and A. Roche, Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group, N Engl J Med 340 (1999), 502-507.
42. A. Hokken-Koelega, Y. van Pareren and N. Arends, Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age, Horm Res 64(Suppl 3) (2005), 95-99.
43. Z. Huma, F. Boulad, P. Black, G. Heller and C. Sklar, Growth in children after bone marrow transplantation for acute leukemia, Blood 86 (1995), 819-824.
44. M.R. Hutchison, M.H. Bassett and P.C. White, Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation, Endocrinology 148 (2007), 3122-3130.
45. E.D. Kakkis, J. Muenzer, G.E. Tiller, L. Waber, J. Belmont, M. Passage, B. Izykowski, J. Phillips, R. Doroshow, I.Walot, R. Hoft and E.F. Neufeld, Enzyme-replacement therapy in mucopolysaccharidosis I, N Engl J Med 344 (2001), 182-188.
46. H. Kanazawa, H. Tanaka, M. Inoue, Y. Yamanaka, N. Namba andY. Seino, Efficacy of growth hormone therapy for patients with skeletal dysplasia, J Bone Miner Metab 21 (2003), 307-310.
47. N. Kandemir, E.N. Gonc and N. Yordam, Responses of bone turnover markers and bone mineral density to growth hormone therapy in children with isolated growth hormone deficiency and multiple pituitary hormone deficiencies, J Pediatr Endocrinol Metab 15 (2002), 809-816.
48. L.L. Key, Jr. and A.J. Gross, Response to growth hormone in children with chondrodysplasia, J Pediatr 128 (1996), S14-S17.
49. G. Khanna, A.E. Van Heest, J. Agel, K. Bjoraker, S. Grewal, S. Abel, W. Krivit, C. Peters and P.J. Orchard, Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation, Bone Marrow Transplant 39 (2007), 331-334.
50. W. Krivit, Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases, Springer Semin Immunopathol 26 (2004), 119-132. (Pubitemid 40021961)
51. R. Lanes, P. Gunczler, S. Esaa and J.R.Weisinger, The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study, Clin Endocrinol (Oxf) 57 (2002), 725-730.
52. L. Legault and Y. Bonny, Endocrine complications of bone marrow transplantation in children, Pediatr Transplant 3 (1999), 60-66.
53. J. Leger, I. Mercat, C. Alberti, D. Chevenne, P. Armoogum, J. Tichet and P. Czernichow, The relationship between the GH/ IGF-I axis and serum markers of bone turnover metabolism in healthy children, Eur J Endocrinol 157 (2007), 685-692.
54. S.E. Lerner, G.J. Huang, D. McMahon, C.A. Sklar and S.E. Oberfield, Growth hormone therapy in children after cranial/ craniospinal radiation therapy: sexually dimorphic outcomes, J Clin Endocrinol Metab 89 (2004), 6100-6104.
55. E.W. Leschek, S.R. Rose, J.A. Yanovski, J.F. Troendle, C.A. Quigley, J.J. Chipman, B.J. Crowe, J.L. Ross, F.G. Cassorla, W.F. Blum, G.B. Cutler, Jr. and J. Baron, Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial, J Clin Endocrinol Metab 89 (2004), 3140-3148.
56. C.E. MacFarlane, D.C. Brown, L.B. Johnston, M.A. Patton, D.B. Dunger, M.O. Savage, W.J. McKenna and C.J. Kelnar, Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up, J Clin Endocrinol Metab 86 (2001), 1953-1956.
57. M.A. Monroy, F.P. Ross, S.L. Teitelbaum and M.S. Sands, Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease, Bone 30 (2002), 352-359.
58. A.M. Montano, S. Tomatsu, A. Brusius, M. Smith and T. Orii, Growth charts for patients affected with Morquio A disease, Am J Med Genet A 146A (2008), 1286-1295.
59. A.M. Montano, S. Tomatsu, G.S. Gottesman, M. Smith and T. Orii, International Morquio A Registry: clinical manifestation and natural course of Morquio A disease, J Inherit Metab Dis 30 (2007), 165-174.
60. J. Muenzer, J.E. Wraith, M. Beck, R. Giugliani, P. Harmatz, C.M. Eng, A. Vellodi, R. Martin, U. Ramaswami, M. Gucsavas-Calikoglu, S. Vijayaraghavan, S. Wendt, A.C. Puga, B. Ulbrich, M. Shinawi, M. Cleary, D. Piper, A.M. Conway and A. Kimura, A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome), Genet Med 8 (2006), 465-473.
61. S.E. Myers, A.L. Carrel, B.Y. Whitman and D.B. Allen, Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome, J Pediatr 137 (2000), 42-49.
62. S.E. Myers, B.Y. Whitman, A.L. Carrel, V. Moerchen, M.T. Bekx and D.B. Allen, Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits, Am J Med Genet A 143 (2007), 443-448.
63. T. Nagai, K. Obata, T. Obata, N. Murakami, Y. Katada, A. Yoshino, S. Sakazume, Y. Tomita, R. Sakuta and N. Niikawa, Growth Hormone Therapy and Scoliosis in Patients with Prader-Willi Syndrome, American Journal of Medical Genetics Part A 140A (2006), 1623-1627.
64. K. Nagashima, H. Endo, K. Sakakibara, Y. Konishi, K. Miyachi, J.J.Wey, Y. Suzuki and J. Onisawa, Morphological and biochemical studies of a case of mucopolysaccharidosis II (Hunter's syndrome), Acta Pathol Jpn 26 (1976), 115-132.
65. E. Neufeld, The Mucopolysaccharidoses, in: The metabolic and molecular basis of inherited disease, C. Scriver, McGraw-Hill, 2001, 3421-3452.
66. J.D. Nuttall, L.K. Brumfield, N.L. Fazzalari, J.J. Hopwood and S. Byers, Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI, Calcif Tissue Int 65 (1999), 47-52.
67. H. Oda, Y. Sasaki, Y. Nakatani, H. Maesaka and S. Suwa, Hunter's syndrome. An ultrastructural study of an autopsy case, Acta Pathol Jpn 38 (1988), 1175-1190.
68. Online Mendelian Inheritance in Man, OMIM, in: Book Online Mendelian Inheritance in Man, OMIM, Editor, McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University and National Center for Biotechnology Information, National Library of Medicine, 2000
69. L.E. Polgreen, J. Tolar, M. Plog, J.H. Himes, P.J. Orchard, C.B. Whitley, B.S. Miller and A. Petryk, Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation, Bone Marrow Transplant 41 (2008), 1005-1011. (Pubitemid 352034175)
70. L.E. Polgreen, M. Plog, J.D. Schwender, J. Tolar,W. Thomas, P.J. Orchard, B.S. Miller and A. Petryk, Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation, Bone Marrow Transplant 44 (2009), 279-285.
71. C. Quigley, A. Gill, B. Crowe, K. Robling, J. Chipman, S. Rose, J. Ross, F. Cassorla, A. Wolka, J.M. Wit, L. Rekers- Mombarg and G. Cutler, Safety of Growth Hormone Treatment in Pediatric Patients with Idiopathic Short Stature, J Clin Endocrinol Metab 90 (2005), 5188-5196.
72. U. Ramaswami, G. Rumsby, H.A. Spoudeas, P.C. Hindmarsh and C.G. Brook, Treatment of achondroplasia with growth hormone: six years of experience, Pediatr Res 46 (1999), 435-439.
73. M.B. Ranke, C.P. Schwarze, R. Dopfer, T. Klingebiel, H.G. Scheel-Walter, P. Lang and D. Niethammer, Late effects after stem cell transplantation (SCT) in children-growth and hormones, Bone Marrow Transplant 35(Suppl 1) (2005), S77-S81.
74. J.L. Ross, D.E. Sandberg, S.R. Rose, E.W. Leschek, J. Baron, J.J. Chipman, F.G. Cassorla, C.A. Quigley, B.J. Crowe, K. Roberts and G.B. Cutler, Jr., Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo, J Clin Endocrinol Metab 89 (2004), 4873-4878.
75. J.L. Ross, Effects of growth hormone on cognitive function, Horm Res 64(Suppl 3) (2005), 89-94.
76. J.L. Ross, P. Feuillan, H. Kushner, D. Roeltgen and G.B. Cutler, Jr., Absence of growth hormone effects on cognitive function in girls with Turner syndrome, J Clin Endocrinol Metab 82 (1997), 1814-1817.
77. J. Rovet and J. Holland, Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group, Horm Res 39(Suppl 2) (1993), 60-64.
78. C. Russell, G. Hendson, G. Jevon, T. Matlock, J. Yu, M. Aklujkar, K.Y. Ng and L.A. Clarke, Murine MPS I: insights into the pathogenesis of Hurler syndrome, Clin Genet 53 (1998), 349-361.
79. G. Saggese, G.I. Baroncelli, S. Bertelloni and S. Barsanti, The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass, J Clin Endocrinol Metab 81 (1996), 3077-3083.
80. R. Schweizer, D.D. Martin, E. Schonau and M.B. Ranke, Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition, J Clin Endocrinol Metab 93 (2008), 2978-2983.
81. R. Schweizer, D.D. Martin, M. Haase, J. Roth, B. Trebar, G. Binder, C.P. Schwarze and M.B. Ranke, Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and smallfor- gestational-age (SGA) children, Bone 41 (2007), 875-881.
82. S. Shalitin, M. Phillip, J. Stein, Y. Goshen, D. Carmi and I. Yaniv, Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence, Bone Marrow Transplant 37 (2006), 1109-1117.
83. M. Sifuentes, R. Doroshow, R. Hoft, G. Mason, I.Walot, M. Diament, S. Okazaki, K. Huff, G.F. Cox, S.J. Swiedler and E.D. Kakkis, A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years, Mol Genet Metab 90 (2007), 171-180.
84. C.P. Silveri, F.S. Kaplan, M.D. Fallon, E. Bayever and C.S. August, Hurler syndrome with special reference to histologic abnormalities of the growth plate, Clin Orthop Relat Res (1991), 305-311.
85. D. Simon, A.M. Prieur, P. Quartier, J. Charles Ruiz and P. Czernichow, Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study, J Clin Endocrinol Metab 92 (2007), 2567-2573.
86. B.W. Soper, A.W. Pung, C.A. Vogler, J.H. Grubb, W.S. Sly and J.E. Barker, Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses, Pediatr Res 45 (1999), 180-186.
87. S.L. Staba, M.L. Escolar, M. Poe, Y. Kim, P.L. Martin, P. Szabolcs, J. Allison-Thacker, S.Wood, D.A.Wenger, P. Rubinstein, J.J. Hopwood, W. Krivit and J. Kurtzberg, Cord-blood transplants from unrelated donors in patients with Hurler's syndrome, N Engl J Med 350 (2004), 1960-1969. (Pubitemid 38580199)
88. N. Tanaka, N. Katsumata, R. Horikawa and T. Tanaka, The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia, Endocr J 50 (2003), 69-75.
89. J. Tolar, S.S. Grewal, K.J. Bjoraker, C.B. Whitley, E.G. Shapiro, L. Charnas and P.J. Orchard, Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome, Bone Marrow Transplant 41 (2008), 531-535. (Pubitemid 351472144)
90. S.P. Toledo, V.H. Costa, R.R. Fukui and N. Abelin, [Serum growth hormone levels in Hunter's syndrome], Rev Hosp Clin Fac Med Sao Paulo 46 (1991), 9-13.
91. A. Tylki-Szymanska and M. Metera, Precocious puberty in three boys with Sanfilippo A (mucopolysaccharidosis III A), J Pediatr Endocrinol Metab 8 (1995), 291-293.
92. L.E. Underwood, K.M. Attie and J. Baptista, Growth hormone (GH) dose-response in young adults with childhoodonset GH deficiency: a two-year, multicenter, multipledose, placebo-controlled study, J Clin Endocrinol Metab 88 (2003), 5273-5280.
93. A. Vellodi, E. Young, M. New, C. Pot-Mees and K. Hugh- Jones, Bone marrow transplantation for Sanfilippo disease type B, J Inherit Metab Dis 15 (1992), 911-918.
94. A. Vellodi, E.P. Young, A. Cooper, J.E. Wraith, B. Winchester, C. Meaney, U. Ramaswami and A.Will, Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres, Arch Dis Child 76 (1997), 92-99.
95. A.Vidil, P. Journeau, A. Soulie, J. Padovani and J. Pouliquen, Evolution of Scoliosis in Six Children Treated wtih Growth Hormone, J Pediatr Orthopaedics Part B 10 (2001), 197-200.
96. E.Wang, D. Drummond, J. Dormans, T. Moshang, R. Davidson and D. Gruccio, Scoliosis in patients treated with growth hormone, J Pediatr Orthop 17 (1997), 708-711.
97. J.S. Weisstein, E. Delgado, L.S. Steinbach, K. Hart and S. Packman, Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation, J Pediatr Orthop 24 (2004), 97-101.
98. C.B. Whitley, The mucopolysaccharidoses, in: McKusick's Heritable Disorders of Connective Tissue, P. Beighton, ed., Mosby, 1993, pp. 367-500.
99. W.M. Widdowson and J. Gibney, The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis, J Clin Endocrinol Metab 93 (2008), 4413-4417.
100. R.H.Willemsen, N.J. Arends, W.M. Bakker-van Waarde, M. Jansen, E.G. van Mil, J. Mulder, R.J. Odink, M. Reeser, C. Rongen-Westerlaken, W.H. Stokvis-Brantsma, J.J.Waelkens and A.C. Hokken-Koelega, Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial, Clin Endocrinol (Oxf) 67 (2007), 485-492.
101. J.E. Wraith, M. Scarpa, M. Beck, O.A. Bodamer, L. De Meirleir, N. Guffon, A. Meldgaard Lund, G. Malm, A.T. Van der Ploeg and J. Zeman, Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy, Eur J Pediatr 167 (2008), 267-277.
102. G. Zhao, M.C. Monier-Faugere, M.C. Langub, Z. Geng, T. Nakayama, J.W. Pike, S.D. Chernausek, C.J. Rosen, L.R. Donahue, H.H. Malluche, J.A. Fagin and T.L. Clemens, Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation, Endocrinology 141 (2000), 2674-2682.
103. G.D. Zimet, R. Owens,W. Dahms, M. Cutler, M. Litvene and L. Cuttler, Psychosocial outcome of children evaluated for short stature, Arch Pediatr Adolesc Med 151 (1997), 1017-1023.